Bazelot M - Search Results

1

Cannabidiol improves survival and behavioural co-morbidities of Dravet syndrome in mice.

Patra PH, Serafeimidou-Pouliou E, Bazelot M, Whalley BJ, Williams CM, McNeish AJ. Patra PH, et al. Among authors: bazelot m. Br J Pharmacol. 2020 Jun;177(12):2779-2792. doi: 10.1111/bph.15003. Epub 2020 Apr 22. Br J Pharmacol. 2020. PMID: 32321192 Free PMC article.

2

Molecular Targets of Cannabidiol in Neurological Disorders.

Ibeas Bih C, Chen T, Nunn AV, Bazelot M, Dallas M, Whalley BJ. Ibeas Bih C, et al. Among authors: bazelot m. Neurotherapeutics. 2015 Oct;12(4):699-730. doi: 10.1007/s13311-015-0377-3. Neurotherapeutics. 2015. PMID: 26264914 Free PMC article. Review.

3

Species-specific susceptibility to cannabis-induced convulsions.

Whalley BJ, Lin H, Bell L, Hill T, Patel A, Gray RA, Elizabeth Roberts C, Devinsky O, Bazelot M, Williams CM, Stephens GJ. Whalley BJ, et al. Among authors: bazelot m. Br J Pharmacol. 2019 May;176(10):1506-1523. doi: 10.1111/bph.14165. Epub 2018 Mar 25. Br J Pharmacol. 2019. PMID: 29457829 Free PMC article.

4

Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models.

Patra PH, Barker-Haliski M, White HS, Whalley BJ, Glyn S, Sandhu H, Jones N, Bazelot M, Williams CM, McNeish AJ. Patra PH, et al. Among authors: bazelot m. Epilepsia. 2019 Feb;60(2):303-314. doi: 10.1111/epi.14629. Epub 2018 Dec 26. Epilepsia. 2019. PMID: 30588604 Free PMC article.

5

Cannabidiol modulates phosphorylated rpS6 signalling in a zebrafish model of Tuberous Sclerosis Complex.

Serra I, Scheldeman C, Bazelot M, Whalley BJ, Dallas ML, de Witte PAM, Williams CM. Serra I, et al. Among authors: bazelot m. Behav Brain Res. 2019 May 2;363:135-144. doi: 10.1016/j.bbr.2019.01.040. Epub 2019 Jan 23. Behav Brain Res. 2019. PMID: 30684511

6

Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity.

Rosenberg EC, Chamberland S, Bazelot M, Nebet ER, Wang X, McKenzie S, Jain S, Greenhill S, Wilson M, Marley N, Salah A, Bailey S, Patra PH, Rose R, Chenouard N, Sun SED, Jones D, Buzsáki G, Devinsky O, Woodhall G, Scharfman HE, Whalley BJ, Tsien RW. Rosenberg EC, et al. Among authors: bazelot m. Neuron. 2023 Apr 19;111(8):1282-1300.e8. doi: 10.1016/j.neuron.2023.01.018. Epub 2023 Feb 13. Neuron. 2023. PMID: 36787750 Free article.

7

μ-Opioid Receptor-Mediated Inhibition of Intercalated Neurons and Effect on Synaptic Transmission to the Central Amygdala.

Blaesse P, Goedecke L, Bazelot M, Capogna M, Pape HC, Jüngling K. Blaesse P, et al. Among authors: bazelot m. J Neurosci. 2015 May 13;35(19):7317-25. doi: 10.1523/JNEUROSCI.0204-15.2015. J Neurosci. 2015. PMID: 25972162 Free PMC article.

8

Hippocampal Theta Input to the Amygdala Shapes Feedforward Inhibition to Gate Heterosynaptic Plasticity.

Bazelot M, Bocchio M, Kasugai Y, Fischer D, Dodson PD, Ferraguti F, Capogna M. Bazelot M, et al. Neuron. 2015 Sep 23;87(6):1290-1303. doi: 10.1016/j.neuron.2015.08.024. Neuron. 2015. PMID: 26402610 Free PMC article.

9

Single CA3 pyramidal cells trigger sharp waves in vitro by exciting interneurones.

Bazelot M, Teleńczuk MT, Miles R. Bazelot M, et al. J Physiol. 2016 May 15;594(10):2565-77. doi: 10.1113/JP271644. Epub 2016 Feb 9. J Physiol. 2016. PMID: 26728572 Free PMC article.

10

Cellular anatomy, physiology and epileptiform activity in the CA3 region of Dcx knockout mice: a neuronal lamination defect and its consequences.

Bazelot M, Simonnet J, Dinocourt C, Bruel-Jungerman E, Miles R, Fricker D, Francis F. Bazelot M, et al. Eur J Neurosci. 2012 Jan;35(2):244-56. doi: 10.1111/j.1460-9568.2011.07962.x. Eur J Neurosci. 2012. PMID: 22250815

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters